CHAPTER 16 Infection prevention and control
Introduction
Infection prevention measures are essential in everyday clinical practice to minimise the risk of infection to patients, their relatives/carers and health care staff. Patients receiving health care, either in a health care facility or at home, may be at increased risk of infection due to their underlying illness or need for treatment. Those being cared for in close proximity to other patients, for example in a hospital ward, are more likely to be exposed to infections harboured by others, particularly given the frequency of contact with health care staff and the sharing of equipment and the environment. In all settings where health care is delivered, it is important for nurses and other health care staff to understand the ways in which infection is spread and the precautions necessary to minimise the risk of spread in order to protect patients, themselves and others from infection. The nurse, along with all other members of the multi-professional team, is responsible for ensuring that infection prevention measures are implemented correctly as part of routine patient care and safety. In this rapidly changing area of practice it is essential for health professionals to keep up to date with the latest evidence and recommended best practice. Throughout the chapter, reference is made to websites that provide current information, evidence-based guidance and other resources for use by health care professionals.
An overview of the problems with and management of health care associated infection and infectious diseases
Health care associated infection (HCAI), previously known as hospital-acquired infection (HAI) and in some countries as nosocomial infection, is the term used to refer to infection acquired during receipt of some form of health care. This updated terminology more accurately reflects the diverse range of settings in which health care is delivered and where infection may arise. There is ongoing concern and activity in the UK, and globally, in relation both to HCAI and the prevention and control of all infectious diseases.
Infectious agents, including different bacteria and viruses capable of rapid spread within health care environments, cause major disruption and impact significantly on the provision of high-quality health care. Currently, these include Clostridium difficile, influenza, norovirus (known as winter vomiting diarrhoeal disease) and respiratory syncytial virus (RSV, in paediatric wards). The occurrence of antimicrobial-resistant microorganisms, such as meticillin-resistant Staphylococcus aureus (MRSA) and glycopeptide-resistant enterococci (GRE), attributed in part to many years of use and misuse of antimicrobial agents, has also risen over the last two decades, causing significant patient safety concerns in UK health care. Common microorganisms, including Staphylococcus aureus, continue to genetically mutate, developing resistance to antimicrobial agents in order to ensure their survival in a changing environment.
The latest HCAI prevalence surveys in adult patients were conducted in 2006 in acute hospitals across England, Wales, Northern Ireland and the Republic of Ireland (Smyth et al 2008) and in 2005–2006 in both acute and non-acute hospitals in Scotland (Reilly et al 2008). The results estimate the prevalence of HCAI to be between 7.3 and 9.5%, which means that at any one time approximately one in eight patients could have an HCAI. Infections associated with invasive procedures and the use of medical devices such as intravascular devices and urinary catheters account for a high proportion of HCAI. Prevalence and incidence results in the UK also reiterate the fact that common microorganisms like those that have already been mentioned continue to cause problems.
It had been thought that up to one third of all HCAIs would be preventable by better application of proven methods of prevention (Haley et al 1985, Harbarth et al 2003). However, more recently it has been claimed that certain HCAIs, in particular central venous catheter-related bloodstream infections, could potentially be eliminated (Pronovost et al 2006). The nurse has a crucial role in achieving this, as described in this chapter.
Less common in the UK, but often with drastic outcomes, are infections spread via the food-borne route. In the past these have had a major impact on both hospital settings and the community. The outbreak of Escherichia coli O157 infection, spread through meat in a butcher’s shop in Wishaw, Lanarkshire, in 1996, resulted in the death of many people within that community and attracted much media interest over hygiene controls in food premises. In hospitals and care facilities, guidance on effective food preparation, production and distribution techniques is vital for effective infection control. The nurse’s role in food hygiene often involves basic measures such as ensuring patients’ own food is in date, stored and reheated correctly. It may also include maintaining correct hygiene procedures relating to enteral feeding systems. Awareness of the importance of food hygiene overall is essential.
Infection prevention and control measures aim to reduce the burden of HCAI and other infectious or communicable diseases, on individuals, health care organisations, and within the National Health Service as a whole. The Health Protection Agency, Health Protection Scotland and Departments of Health in all UK countries coordinate many activities, such as national surveillance and control programmes, in order to highlight and act upon the actual burden in specific settings (see Useful websites, p. 515). Nurses are well placed to contribute to the prevention, control and management of infection within health care settings and beyond. Indeed, nurses occupy a wide diversity of roles, including those concerned with public health, providing ever-increasing opportunities to influence the health protection and patient safety agendas.
For further information about the national burden of HCAI and spread of other infectious diseases, see the recent national prevalence surveys (Reilly et al 2008, Smyth et al 2008), National Audit Office reports (2000, 2004, 2009), the Care Quality Commission’s work, the UK Health Department websites, the Health Protection Agency and Health Protection Scotland websites (see Useful websites, p. 516).
How infection spreads
The terms ‘infection process’, ‘cycle of infection’ and ‘chain of infection’ are often used to describe the circumstances that can lead to patients or others developing an HCAI or any infectious disease. The rationale for applying infection prevention measures is based on this chain of events. It is crucial to understand how microorganisms spread and infection occurs. The infection process involves:
The principles relating to all infection prevention measures are based on the interruption of this process. If these measures are not taken, a cycle will continue whereby patients, and possibly staff and others, may be exposed to potentially pathogenic (disease-causing) microorganisms that can cause harm.
Microbiology
Microbiology is the study of microorganisms and other causes of infection, including bacteria, viruses, fungi, protozoa, prions and helminths.
Bacteria
Bacteria, including variations of the microscopic beings such as mycoplasmas, rickettsiae and chlamydiae, are small microorganisms of simple primitive form. Bacteria are commonly found living within the human body and in the environment, for example in soil and water. Those species of bacteria capable of causing disease in humans are known as ‘pathogens’. Some are more ‘pathogenic’ than others. Most are acquired though contact with other people or the environment (i.e. ‘exogenous’ sources). Table 16.1 gives some examples of pathogenic bacteria commonly encountered while providing health care. Bacteria that constitute the normal commensal flora within the body are not normally pathogenic (Table 16.2). However, in certain situations, such as when these bacteria gain access to a different anatomical location within the body, they can cause disease. This is known as ‘endogenous’ infection. It is not always clear when infections are exogenous or endogenous.
Table 16.2 Normal commensal microorganisms
Site | Organism |
---|---|
Skin | Staphylococcus epidermidis |
Diphtheroids | |
Corynebacterium sp. | |
Mouth and throat | Staphylococci |
Streptococci | |
Anaerobes | |
Neisseria sp. | |
Nose | Staphylococci |
Diphtheroids | |
Gut | Escherichia coli |
Klebsiella sp. | |
Proteus sp. | |
Streptococcus faecalis | |
Clostridium perfringens | |
Yeasts (Candida) | |
Kidneys and bladder | Normally sterile |
Vagina | Lactobacilli |
Streptococci | |
Staphylococci | |
Anaerobes |
Viruses
Viruses are a group of parasitic infective agents so small that they are visible only through electron microscopy. Viruses have no independent metabolic activity and may replicate only within the cell of a living plant, animal or human. Viruses in humans therefore tend to spread due to close human contact, although some can also survive and be spread through environmental contamination.
Fungi
Fungi are simple plants that are parasitic on other plants, animals and humans. A few can cause fatal disease and illness in humans. Fungi can cause ‘opportunistic’ infection in people with increased susceptibility to infection. For example, in a postoperative patient, where antibiotic therapy may not only eradicate the infective organism but also protective normal flora, fungi such as Candida albicans can proliferate and cause infection.
Protozoa
Protozoa are single-cell microbes, which are the smallest organism in the animal kingdom. Some species can cause human disease, particularly in hot climates. Examples include Plasmodium, the protozoan that causes malaria, and Entamoeba histolytica, which causes amoebic dysentery. Protozoal infections do not pose a risk of person-to-person spread within health care settings, as depending on the type, they are spread via contaminated water or food, insect bites or sexual intercourse.
Prions
Prions are minute protein particles that cause transmissible spongiform encephalopathies (TSEs) in humans and animals. Creutzfeldt–Jakob disease (CJD) is a human TSE which is fatal. It causes the destruction of neural tissue, leading to progressive brain damage. Variant CJD (vCJD) has been associated with cases in young people.
Helminths
Helminths are worms, some of which can be a major cause of morbidity in humans, mainly in developing countries. In the Western world, many species of helminths can infest humans. These are most frequently spread within a household or shared living space and are not commonly encountered in the context of health care.
For further information on all microorganisms, see Gould & Brooker (2008) and Wilson (2000).
Routes of transmission
Clear understanding of the most common routes or means of transmission of microorganisms can ensure that appropriate precautions are taken to minimise the risk of spread of infection in all situations.
Certain organisms can be transmitted through more than one of these routes and all modes of spread must be considered when carrying out risk assessments and providing safe care.
The infection prevention team
Health care workers, patients, relatives and carers together have a contribution to make in the prevention, control and management of the spread of infection. Those involved include nurses, doctors and dentists, allied health professionals, microbiology laboratory scientists, health care assistants, domestic and catering services, estates management, sterile services staff, administrative and management staff, education and training staff.
The role of the infection prevention team (IPT) has been defined and includes the utilisation of the risk management approach (see p. 505), provision of relevant specialist advice, ensuring appropriate measures and action plans are in place and supporting sustained improvement through a change of culture throughout their health care organisation. The team has clear accountability for reporting infection prevention and control progress and issues through relevant management structures, such as clinical governance and patient safety committees and, at times, directly to chief executives. The infection prevention doctor (IPD) and infection prevention nurse (IPN) have clear responsibilities within the health care organisation. More recently, leadership and management roles, including the Nurse Consultant, Director of Infection Prevention and Control (in England and Wales) and Infection Control Manager (in Scotland) have added to the structure.
Many settings also have infection prevention link personnel to enhance the effectiveness of the work of the team. The link person in a ward, department or community team receives additional education to improve the communication between infection prevention and control teams and the clinical setting and may assist with clinical audit and awareness of clinical staff in relation to Standard Precautions (see p. 507).
The nurse’s role in infection prevention
Nurses can contribute to all aspects of infection prevention in clinical practice, acting as role models and educating others. Nurses have a pivotal role in managing infection in acute and primary care settings by:
Nurses in the UK have a duty of care as stated in the Health and Safety at Work Act (1974) to prevent, control and manage infection. Nurses, as the largest staff group in health care, have a responsibility to deliver care based on the best available evidence or best practice (Nursing and Midwifery Council [NMC] 2008). This includes preventing the spread of infection, ensuring they do not put themselves and others at unnecessary risk from infection. In England and Wales, The Health and Social Care Act (DH 2008, p. 2) requires health care professionals to ‘demonstrate good infection control and hygiene practice’.
The health of nurses while at work is also important. Nurses should:
Diagnostic sampling
The collection of specimens for microbiological examination is an important element of a nurse’s role. It enables identification of microorganisms to aid diagnosis and ensure appropriate treatment. In the case of bacterial infection, accurate diagnosis enables the use of narrow-spectrum rather than broad-spectrum antimicrobial agents, which optimises treatment and reduces problems associated with antimicrobial use. A sample may also be taken for screening purposes, e.g. to exclude previous known infections or as part of contact tracing. The UK countries currently have a range of policies on screening for antimicrobial-resistant organisms and, in particular, MRSA (see Useful websites p. 516).
The value of swab sampling is frequently questioned, but it is a common, convenient and inexpensive option in clinical practice. If contamination occurs, for example, from intact skin surrounding a suspected infected surgical wound (false positive), or not enough sample is sent to the laboratory, for example a dry swab is used to sample a small patch of dry skin for microbiological screening purposes (false negative), analysis will be limited and results will not be meaningful. Accurate completion of laboratory forms is also essential to provide laboratory staff with the information needed to select appropriate diagnostic tests. Whilst demographic information about the patient is often computer generated nowadays, relevant information about the patient’s condition, current medication or treatments (e.g. antibiotics), the source of the specimen and its purpose (e.g. screening or confirming the diagnosis of infection) is important to include.
Epidemiology
Epidemiology is the study of disease in relation to populations, e.g. who is being affected by MRSA or influenza, and when and where they are being affected. Epidemiological data are crucial in guiding actions and therefore all staff should support and become involved in collecting data and taking on board feedback in order to enhance targeted patient care and treatment. A population considered at risk, for example from Clostridium difficile, could be monitored using epidemiological methods to gather information which relates the disease to the population by studying both ill and healthy individuals. Epidemiology is closely linked with risk assessment and management. Results of epidemiological monitoring help to affect outcomes, for example reductions in infection rates by influencing infection prevention and control measures featured in, for example, action plans and care plans.
In order to identify infectious diseases including HCAI, methods must be in place to gather the appropriate information to inform knowledge of the distribution of such diseases. There are various ways to monitor disease.
Data collected over time show the changing patterns of infectious diseases in our society, providing information about newly emerging diseases and identifying specific problem areas, e.g. outbreaks and seasonality of diseases. This informs the risk management process, which contributes to the prevention of infections and the control of outbreaks of infection.
Mandatory surveillance systems are in place throughout the UK and tools are provided to support the collection and collation of data. It is important that principles, including definitions, for epidemiological monitoring are followed to allow for reliable and comparable data in order to show improvement or deterioration over time.
The risk management approach
The risk to health from infection is one of many risks to be managed in health care settings. The risk management approach to HCAI was developed during the 1970s as part of the growing health and safety agenda around the developed world. The World Health Organization (WHO 2008) definitions provide a basis for the risk management approach in relation to infection prevention and control:
Hazards and risks from microorganisms are present in our environment at all times. Once they are identified, appropriate control measures and action plans must be adopted to ensure that the greatest time and resource is spent in the areas with the greatest risks of infection. For example, the approach to the management of MRSA within the health care environment varies according to the risk to patients. In the hospital environment and, in particular, wards and units where patients are deemed to be at high risk of infection with MRSA, such as intensive care units and orthopaedic surgical wards, a more stringent approach to screening, decolonisation treatment and the isolation of patients colonised or infected with MRSA may be taken, as compared with community settings such as care homes and the patient’s own home (Box 16.1). As hazards and risks may change over time, up-to-date guidance on infection prevention and control measures is required for the health and safety of patients and staff.
Mr Brown’s journey
The following scenario concerns an infectious condition that is commonly encountered, both in community and hospital settings. From the information provided, consider: (i) Mr Brown’s susceptibility to infection before admission to hospital; (ii) how Mr Brown’s susceptibility to infection will be affected by his hospital admission and need for surgery; (iii) the ways in which infection risks can be minimised both to Mr Brown and other patients on the ward.
Mr Brown is due to be admitted to hospital for total hip replacement surgery. He is assessed in the outpatients’ clinic 2 weeks before his operation is due. He is 62 years old with type 2 diabetes, treated by hypoglycaemics. On assessment, the significant factors noted are: he is overweight and is a smoker, he states that he eats well and controls his diabetes, his skin is dry in places and he is a social drinker.
His wife is with him and is recovering from a hysterectomy, for which she was discharged from hospital 4 weeks ago. It later transpires that she is continuing to see the practice nurse for an ongoing postoperative wound problem.
Mr Brown is found to have a foot ulcer. During examination of the foot ulcer, signs and symptoms of infection are present, i.e. erythema (redness), swelling and heat, with evidence of scanty serous exudate. Samples are taken and sent to the microbiology laboratory. Also, a nose swab is taken to screen for MRSA. The multidisciplinary team are eager to manage and treat the ulcer appropriately in order to progress with Mr Brown’s proposed hip surgery and are considering antibiotic therapy on results of the samples taken.
The results from Mr Brown’s MRSA screen and foot ulcer yielded MRSA.
Activities
NB: Further critical thinking questions relating to this scenario are available on the website.

Stay updated, free articles. Join our Telegram channel

Full access? Get Clinical Tree

